Complications of transplanted liver – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 05 Jun 2026 10:54:53 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Complications of transplanted liver – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study of Darbepoetin Alfa to Reduce Blood Transfusion Needs During Liver Transplant Surgery https://clinicaltrials.eu/trial/study-of-darbepoetin-alfa-to-reduce-blood-transfusion-needs-during-liver-transplant-surgery/ Wed, 29 Apr 2026 15:07:30 +0000 https://clinicaltrials.eu/trial/study-of-darbepoetin-alfa-to-reduce-blood-transfusion-needs-during-liver-transplant-surgery/ This study focuses on patients who are candidates for liver transplantation and have low blood levels. The research evaluates the effectiveness and safety of darbepoetin alfa, a medication produced using gene technology in hamster ovary cells. This medicine is given as an injection under the skin to help increase blood levels before transplant surgery.

The main purpose of the study is to determine if using darbepoetin alfa can reduce the need for blood transfusions during liver transplant surgery. The medication will be given to patients who are on the waiting list for liver transplantation and have low hemoglobin levels (a protein that carries oxygen in the blood).

The treatment period lasts up to three months, during which patients receive darbepoetin alfa injections. The study will monitor various aspects of patient health, including blood levels, complications related to liver disease, quality of life, and any side effects from the treatment. Researchers will continue to follow patients for up to one year after their transplant surgery to assess their recovery and the success of the transplant.

]]>